Compounds > ofloxacin

ofloxacin and meropenem

ofloxacin has been researched along with meropenem in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (13.16)18.2507
2000's19 (50.00)29.6817
2010's14 (36.84)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N1
Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L1
Fujimoto, S; Ike, Y; Okuzumi, K; Tanimoto, K; Tomita, H1
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Girlich, D; Nordmann, P; Poirel, L1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Masuda, N; Ohya, S1
Tuohy, M; Washington, JA1
Appelbaum, PC; Jacobs, MR; Visalli, MA1
Ho, SW; Hsueh, PR; Jan, IS; Luh, KT; Teng, LJ1
Arita, K; Daido, K; Kohara, T; Nakamura, K; Ohashi, N; Takeshima, Y1
Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D1
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T1
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E1
Furugo, I; Ishida, M; Takii, M; Ueda, M1
Erdem, I; Goktas, P; Kaya, B; Kaynar-Tascioglu, J1
De Vecchi, E; Drago, L; Gismondo, MR; Lombardi, A; Nicola, L; Valli, M1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Entenza, J; Flatz, L; Kühn, F; Stucki, A1
Burgess, DS; Frei, CR; Moczygemba, LR1
Engel, AE; Glass, D; Li, C; Wexler, HM1
Adam, HJ; Laing, N; Mayer, M; Zhanel, GG1
Ito, K; Izumi, K; Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K1
Bahniuk, N; Brown, DL; Drusano, GL; Grasso, C; Kulawy, R; Louie, A; Van Scoy, B1
Ashcraft, DS; Pankey, GA1
Ozbek, B; Sentürk, A1
Flores, B; Rickert, K; Samson, D; Yu, W1
Hsu, LY; Kwa, AL; Lee, W; Lim, TP; Sasikala, S; Syahidah, N; Tan, TT; Tan, TY; Teo, J1
Cullen, IM; Fennell, JP; Flynn, RJ; Grainger, R; Manecksha, RP; McDermott, T; McEvoy, E; Nason, GJ; Thornhill, JA1
Kaniga, K; Lee, M; Redman, R; Rice, DA1
Hoshino, K; Kanda, H; Uoyama, S; Yoshida, K1
English, AM; Khakimova, M; Martins, D; McKay, G; Nguyen, D; Sampathkumar, G1

Reviews

1 review(s) available for ofloxacin and meropenem

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for ofloxacin and meropenem

ArticleYear
[Effectiveness of switch therapy for peritonitis].
    The Japanese journal of antibiotics, 2007, Volume: 60, Issue:4

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Health Care Costs; Humans; Injections, Intravenous; Meropenem; Middle Aged; Naphthyridines; Ofloxacin; Oxazines; Peritonitis; Thienamycins

2007
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013

Other Studies

35 other study(ies) available for ofloxacin and meropenem

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal

2007
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey

2008
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Base Sequence; beta-Lactam Resistance; Carbapenems; DNA Primers; DNA, Bacterial; Doripenem; Fluoroquinolones; Genes, Bacterial; Humans; In Vitro Techniques; Meropenem; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2008
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology

2010
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacteriophages; beta-Lactamases; Cefsulodin; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Meropenem; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa; Thienamycins; Transduction, Genetic

1992
Antimicrobial susceptibility of viridans group streptococci.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin

1997
Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Thienamycins; Time Factors

1998
Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 1998, Volume: 97, Issue:10

    Topics: Anti-Infective Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Ciprofloxacin; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Ofloxacin; Thienamycins

1998
[Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:7

    Topics: Anti-Infective Agents; beta-Lactam Resistance; Carbapenems; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Ofloxacin; Pseudomonas aeruginosa; Thienamycins

1999
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin

2000
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins

2000
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins

2001
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:3

    Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins

2002
The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2002
Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:6

    Topics: Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Penicillins; Thienamycins

2002
Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:11

    Topics: Animals; Disease Models, Animal; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Polymerase Chain Reaction; Rabbits; Reference Values; Sensitivity and Specificity; Streptococcus pneumoniae; Thienamycins

2003
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Clinical therapeutics, 2004, Volume: 26, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins

2004
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Thienamycins

2005
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftazidime; Colistin; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Mutation; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Thienamycins; Tobramycin

2006
The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Genes, Bacterial; Humans; In Vitro Techniques; Levofloxacin; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2010
In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia.
    Diagnostic microbiology and infectious disease, 2010, Volume: 67, Issue:3

    Topics: Anti-Bacterial Agents; Drug Synergism; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Ofloxacin; Stenotrophomonas maltophilia; Thienamycins

2010
Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Chemotherapy, 2010, Volume: 56, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Thienamycins; Tigecycline

2010
Infectious mid basilar artery aneurysm from Pseudomonas meningitis.
    Journal of neurointerventional surgery, 2012, Volume: 4, Issue:3

    Topics: Adult; Angiography, Digital Subtraction; Anti-Bacterial Agents; Carotid Artery, Internal, Dissection; Cerebral Angiography; Female; Humans; Image Processing, Computer-Assisted; Intracranial Aneurysm; Meningitis, Bacterial; Meropenem; Ofloxacin; Ophthalmic Artery; Pseudomonas Infections; Thienamycins

2012
Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B.
    PloS one, 2011, Volume: 6, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Phylogeny; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Thienamycins; Time Factors

2011
Prospective study of antibiotic prophylaxis for prostate biopsy involving >1100 men.
    TheScientificWorldJournal, 2012, Volume: 2012

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fever; Humans; Male; Meropenem; Middle Aged; Ofloxacin; Prospective Studies; Prostate; Prostatic Neoplasms; Quinolones; Sepsis; Thienamycins; Treatment Outcome

2012
[Bactericidal effect of levofloxacin injection in combination with meropenem against Pseudomonas aeruginosa using an in vitro simulation model with a hollow fiber system].
    The Japanese journal of antibiotics, 2012, Volume: 65, Issue:6

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Thienamycins

2012
Superoxide dismutase activity confers (p)ppGpp-mediated antibiotic tolerance to stationary-phase
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 09-25, Volume: 115, Issue:39

    Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Gentamicins; Ligases; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Signal Transduction; Superoxide Dismutase; Thienamycins

2018